312 related articles for article (PubMed ID: 15618151)
1. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.
Donnelly S; O'Neill SM; Sekiya M; Mulcahy G; Dalton JP
Infect Immun; 2005 Jan; 73(1):166-73. PubMed ID: 15618151
[TBL] [Abstract][Full Text] [Related]
2. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.
Donnelly S; Stack CM; O'Neill SM; Sayed AA; Williams DL; Dalton JP
FASEB J; 2008 Nov; 22(11):4022-32. PubMed ID: 18708590
[TBL] [Abstract][Full Text] [Related]
3. Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica.
Miller CM; Smith NC; Ikin RJ; Boulter NR; Dalton JP; Donnelly S
PLoS One; 2009 May; 4(5):e5692. PubMed ID: 19478853
[TBL] [Abstract][Full Text] [Related]
4. The absence of MyD88 has no effect on the induction of alternatively activated macrophage during Fasciola hepatica infection.
Luo H; Huang W; Wang D; Wang H; Nie K
BMC Immunol; 2011 Nov; 12():63. PubMed ID: 22074389
[TBL] [Abstract][Full Text] [Related]
5. Fasciola hepatica tegumental antigens indirectly induce an M2 macrophage-like phenotype in vivo.
Adams PN; Aldridge A; Vukman KV; Donnelly S; O'Neill SM
Parasite Immunol; 2014 Oct; 36(10):531-9. PubMed ID: 25039932
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin peroxidase secreted by Echinococcus granulosus (sensu stricto) promotes the alternative activation of macrophages via PI3K/AKT/mTOR pathway.
Wang H; Zhang CS; Fang BB; Li ZD; Li L; Bi XJ; Li WD; Zhang N; Lin RY; Wen H
Parasit Vectors; 2019 Nov; 12(1):542. PubMed ID: 31727141
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin 4, interleukin 4 splice variants and interferon gamma mRNA in calves experimentally infected with Fasciola hepatica.
Waldvogel AS; Lepage MF; Zakher A; Reichel MP; Eicher R; Heussler VT
Vet Immunol Immunopathol; 2004 Jan; 97(1-2):53-63. PubMed ID: 14700537
[TBL] [Abstract][Full Text] [Related]
8.
Jin QW; Zhang NZ; Li WH; Qin HT; Liu YJ; Ohiolei JA; Niu DY; Yan HB; Li L; Jia WZ; Song MX; Fu BQ
Front Immunol; 2020; 11():2015. PubMed ID: 33072069
[No Abstract] [Full Text] [Related]
9. Alternative activation of ruminant macrophages by Fasciola hepatica.
Flynn RJ; Irwin JA; Olivier M; Sekiya M; Dalton JP; Mulcahy G
Vet Immunol Immunopathol; 2007 Nov; 120(1-2):31-40. PubMed ID: 17719651
[TBL] [Abstract][Full Text] [Related]
10. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses.
Dowling DJ; Hamilton CM; Donnelly S; La Course J; Brophy PM; Dalton J; O'Neill SM
Infect Immun; 2010 Feb; 78(2):793-801. PubMed ID: 19917714
[TBL] [Abstract][Full Text] [Related]
11. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses.
Walsh KP; Brady MT; Finlay CM; Boon L; Mills KH
J Immunol; 2009 Aug; 183(3):1577-86. PubMed ID: 19587018
[TBL] [Abstract][Full Text] [Related]
12. PD-L2 negatively regulates Th1-mediated immunopathology during Fasciola hepatica infection.
Stempin CC; Motrán CC; Aoki MP; Falcón CR; Cerbán FM; Cervi L
Oncotarget; 2016 Nov; 7(47):77721-77731. PubMed ID: 27783986
[TBL] [Abstract][Full Text] [Related]
13. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis.
Brady MT; O'Neill SM; Dalton JP; Mills KH
Infect Immun; 1999 Oct; 67(10):5372-8. PubMed ID: 10496919
[TBL] [Abstract][Full Text] [Related]
14. Cattle co-infection of Echinococcus granulosus and Fasciola hepatica results in a different systemic cytokine profile than single parasite infection.
Corrêa F; Hidalgo C; Stoore C; Jiménez M; Hernández M; Paredes R
PLoS One; 2020; 15(9):e0238909. PubMed ID: 32915902
[TBL] [Abstract][Full Text] [Related]
15. Fasciola hepatica infection downregulates Th1 responses in mice.
O'Neill SM; Brady MT; Callanan JJ; Mulcahy G; Joyce P; Mills KH; Dalton JP
Parasite Immunol; 2000 Mar; 22(3):147-55. PubMed ID: 10672196
[TBL] [Abstract][Full Text] [Related]
16. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability.
Rodríguez-Sosa M; Satoskar AR; Calderón R; Gomez-Garcia L; Saavedra R; Bojalil R; Terrazas LI
Infect Immun; 2002 Jul; 70(7):3656-64. PubMed ID: 12065507
[TBL] [Abstract][Full Text] [Related]
17. Newly excysted juveniles (NEJs) of Fasciola gigantica induce mice liver fibrosis and M2 macrophage-like phenotype in vivo.
Zhang Y; Mei X; Liang Y; Zhu B; Sheng Z; Shi W; Wang D; Huang W
Microb Pathog; 2020 Feb; 139():103909. PubMed ID: 31805319
[TBL] [Abstract][Full Text] [Related]
18. Eosinophils Control Liver Damage by Modulating Immune Responses Against
Frigerio S; da Costa V; Costa M; Festari MF; Landeira M; Rodríguez-Zraquia SA; Härtel S; Toledo J; Freire T
Front Immunol; 2020; 11():579801. PubMed ID: 33042162
[TBL] [Abstract][Full Text] [Related]
19. Possible role for Toll-like receptors in interaction of Fasciola hepatica excretory/secretory products with bovine macrophages.
Flynn RJ; Mulcahy G
Infect Immun; 2008 Feb; 76(2):678-84. PubMed ID: 18070895
[TBL] [Abstract][Full Text] [Related]
20. Excretory/secretory products from two Fasciola hepatica isolates induce different transcriptional changes and IL-10 release in LPS-activated bovine "BOMA" macrophages.
Bąska P; Norbury LJ; Zawistowska-Deniziak A; Wiśniewski M; Januszkiewicz K
Parasitol Res; 2017 Oct; 116(10):2775-2782. PubMed ID: 28823007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
